Description

Ethyl 2-Ethyl-3-Methyl-6-Oxo-6,7-Dihydro-2H-Pyrazolo[3,4-B]Pyridine-4-Carboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the fused pyrazolopyridine class of heterocyclic compounds. This compound is of significant commercial value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs) and agrochemicals. It is primarily sought after by research institutions and manufacturing facilities in the pharmaceutical, agrochemical, and fine chemical industries for developing new therapeutic and crop protection agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the research and synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, inflammation, and metabolic diseases.
• Agrochemical Synthesis: Serves as a key building block for developing new-generation pesticides, herbicides, and fungicides with enhanced efficacy and selectivity.
• Organic Synthesis & Research: Used in academic and industrial R&D laboratories for constructing complex heterocyclic frameworks and exploring new chemical spaces in medicinal chemistry.
• Fine Chemical Production: Employed in the manufacture of specialty chemicals, dyes, and other performance materials requiring a sophisticated pyrazolopyridine core structure.

Basic Information

Item	Details
Product Name	Ethyl 2-Ethyl-3-Methyl-6-Oxo-6,7-Dihydro-2H-Pyrazolo[3,4-B]Pyridine-4-Carboxylate
CAS No.	1092184-52-5
Molecular Formula	C₁₄H₁₇N₃O₃
Molecular Weight	275.30 g/mol
Synonyms	Ethyl 2-ethyl-3-methyl-6-oxo-6,7-dihydro-2H-pyrazolo[3,4-b]pyridine-4-carboxylate; 2H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6,7-dihydro-2-ethyl-3-methyl-6-oxo-, ethyl ester; 4-Carbethoxy-2-ethyl-3-methyl-6-oxo-6,7-dihydro-2H-pyrazolo[3,4-b]pyridine; Ethyl 2-ethyl-3-methyl-6-oxo-2,6,7,8-tetrahydropyrazolo[3,4-b]pyridine-4-carboxylate; 1092184-52-5; Fused Pyrazolopyridine Derivative
EINECS	Contact for details

Quality Control

Our Ethyl 2-Ethyl-3-Methyl-6-Oxo-6,7-Dihydro-2H-Pyrazolo[3,4-B]Pyridine-4-Carboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your most demanding synthesis workflows.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat, open flames, and incompatible materials. As a light-sensitive compound, containers should be opaque or stored in dark conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.